“Author TBD”: Radical Collaboration in Contemporary Biomedical Research
Author:
- 1 December 2012
- journal article
- Published by Cambridge University Press (CUP) in Philosophy of Science
- Vol. 79 (5) , 845-858
Abstract
Ghostwriting scandals are pervasive in industry-funded biomedical research, and most responses to them have presumed that they represent a sharp transgression of the norms of scientific authorship. I argue that in fact, ghostwriting represents a continuous extension of current socially accepted authorship practices. I claim that the radically collaborative, decentralized, interdisciplinary research that forms the gold standard in medicine is in an important sense unauthored, and that this poses a serious problem in applied social epistemology. It is no easy matter to find procedural or architectural solutions that can secure epistemic trust and accountability for collaborative publishing in biomedicine.Keywords
This publication has 16 references indexed in Scilit:
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2011
- Liberal or Restrictive Transfusion in High-Risk Patients after Hip SurgeryNew England Journal of Medicine, 2011
- Boceprevir for Untreated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- PUBLICATION ETHICS AND THE GHOST MANAGEMENT OF MEDICAL PUBLICATIONBioethics, 2010
- Ghost Marketing: Pharmaceutical Companies and Ghostwritten Journal ArticlesPerspectives in Biology and Medicine, 2007
- Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?PLOS Medicine, 2007
- BiDil: Race Medicine Or Race Marketing?Health Affairs, 2005
- Interface between authorship, industry and science in the domain of therapeuticsThe British Journal of Psychiatry, 2003
- The Role of Trust in KnowledgeThe Journal of Philosophy, 1991
- The Scientist Qua Scientist Makes Value JudgmentsPhilosophy of Science, 1953